c-Myc and EZH2 interact in glioblastoma CSCs, and c-Myc overexpression rescues the inhibitory effect of 3-deazaneplanocin A, an EZH2 inhibitor, on targeted glioblastoma CSCs [29]. This evidence concerns the gene MYC and glioblastoma.